SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-23-014815
Filing Date
2023-04-26
Accepted
2023-04-26 16:15:44
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-26

Document Format Files

Seq Description Document Type Size
1 ARS pstx_ars_2023.pdf ARS 2605472
  Complete submission text file 0000950170-23-014815.txt   3589168
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39376 | Film No.: 23849928
SIC: 2836 Biological Products, (No Diagnostic Substances)